Track topics on Twitter Track topics that are important to you
AstraZeneca is just days away from unveiling data from its MYSTIC trial, a new lung cancer immunotherapy combination which carries huge expectations for the company. The MYSTIC trial combines the company’s Imfinzi (PD-L1 drug durvalumab, already...
Original Article: As Mystic unveiling nears, AZ keeps cancer options open with Chi-MedNEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...